Influence of fluvastatin alone and its combination with aspirin and trental on hemostasis and microcirculation in atherosclerosis

Terapevticheskii Arkhiv

Volumn 74, Issue 8, 2002, Pages 9-12

  Zhdanova, I V ^a   Tsvirenko, S V ^a   Barats, S S ^a   Smolenskaya, O G ^a   Volkova, R F ^a   Serezhenko, T O ^a  

^a NONE

Author keywords

Aspirin; Atherosclerosis; Fluvastatin; Hemostasis; Microcirculation; Trental

Indexed keywords

ACETYLSALICYLIC ACID; FLUINDOSTATIN; HYPOCHOLESTEROLEMIC AGENT; INDOLE DERIVATIVE; MONOUNSATURATED FATTY ACID; PENTOXIFYLLINE;

ADULT; AGED; ARTERIOSCLEROSIS; ARTICLE; DRUG COMBINATION; DRUG EFFECT; FEMALE; HEMOSTASIS; HUMAN; MALE; MICROCIRCULATION; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; AGED; ANTICHOLESTEREMIC AGENTS; ARTERIOSCLEROSIS; ASPIRIN; DRUG THERAPY, COMBINATION; FATTY ACIDS, MONOUNSATURATED; FEMALE; HEMOSTASIS; HUMANS; INDOLES; MALE; MICROCIRCULATION; MIDDLE AGED; PENTOXIFYLLINE;

EID: 11244319357     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Sirtort C. R., Colli S Influences of lipid-modifying agents on hemostasis. Cardiovasc Drugs Ther 1993; 7 (5): 817-823.
2. Miller G. J. Lipoproteins and thrombosis: effects of lipid lowering Curr. Opin. Lipidol. 1995, 6 (1). 38-42.
3. Ambrosi P., Juhan-Vague I Dyslipidemia, lipid-lowering drugs and thrombosis. Arch. Mal. Coeur. 1995, 88 (11): 1641-1645.
4. Sinzinger H., Palumbo B., Palumbo R. Atorvastatin improves vascular thrombogenicity. In: XIII International symposium on drugs affecting lipid metabolism: (Abstract book). Florence; 1998 24
5. th International symposium on atherosclerosis, held in Paris, France, on 5-7 Oct. 1997 Amsterdam. Elsevier Science; 1998, 289-293.
6. Schmieder R. E., John S., Schlaich M. R. et al. Lowering of LDL-cholesterol improves endothelial function by increased nitric oxide synthas activity. Atherosclerosis 1997; 134: 61
7. Camera M., Gaviraghi M., Tremoli E. Fluvastatin inhibits TNFα and LPS-induced c-Rel/p65 nuclear translocation and tissue factor expression in human endothelial cells. Atherosclerosis 1997; 134: 239-240.
8. Tremoli E., Camera M., Colli S. Tissue factor in atherosclerosis: effects of HMG-CoA reductase inhibitors. In: XIII International symposium on drugs affecting lipid metabolism: (Abstract book). Florence; 1998, 24
9. Corsini A. New insights in to statins: focus on antiatherosclerotic mechanisms and drugs interaction. Ibid. 71.